Skip to content
★ Sign in to follow
EL

Eva Lindgren

IRLAB Therapeutics AB
Total declarations
5
Company
1
▲ Purchases (1 ops.)
€42k
▼ Sales (0 ops.)
—

Latest filing published 28 Feb 2020 for IRLAB Therapeutics AB, €7,987.

Filing timeline

BuySale
Eva Lindgren

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Eva Lindgren: trading record in brief

All filings by Eva Lindgren on record concern IRLAB Therapeutics AB. In total, 5 filings cover trades dated from 24 February 2017 to 26 February 2020.

On the market, this insider has only ever bought: 1 purchase, €42k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

On 28 February 2020 came the latest disclosure, a transaction for €7,987 in IRLAB Therapeutics AB. The clock since the last published purchase (28 February 2017) now reads 3,540 days. Filings reach the Finansinspektionen feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Eva Lindgren

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ●
    Styrelseledamot/suppleantExecutivesIRLAB Therapeutics AB
    84,510 SEK0FI-SE
    3,130 shares@ SEK 27.0035.6% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-6353ff7587cee2741b09
  • ●
    Styrelseledamot/suppleantExecutivesIRLAB Therapeutics AB
    152,982 SEK0FI-SE
    5,666 shares@ SEK 27.0064.4% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-6a83f314eb05720d3430
  • ●
    Styrelseledamot/suppleantExecutivesIRLAB Therapeutics AB
    2M SEK0FI-SE
    19,384 shares@ SEK 88.71AktieISIN SE0012675379FI:csv-64d899cfb9153525c6ae
  • ▲
    Styrelseledamot/suppleantExecutivesIRLAB Therapeutics AB
    399,960 SEK0FI-SE
    6,666 shares@ SEK 60.00FI:csv-2ac59906cb94c4d21fee
    Canonical exit: 25 May 2017 (T+90)

4 of 4 declarations